<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-molecules-24-01552">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wagoner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Morishima</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Graf</surname>
    <given-names>T.N.</given-names>
   </name>
   <name>
    <surname>Oberlies</surname>
    <given-names>N.H.</given-names>
   </name>
   <name>
    <surname>Teissier</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>PÃ©cheur</surname>
    <given-names>E.-I.</given-names>
   </name>
   <name>
    <surname>Tavis</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Polyak</surname>
    <given-names>S.J.</given-names>
   </name>
  </person-group>
  <article-title>Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation</article-title>
  <source>PLoS ONE</source>
  <year>2011</year>
  <volume>6</volume>
  <elocation-id>e16464</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0016464</pub-id>
  <?supplied-pmid 21297992?>
  <pub-id pub-id-type="pmid">21297992</pub-id>
 </element-citation>
</ref>
